ES2762866T3 - Reemplazo de nucleótidos por bibliotecas doblemente etiquetadas y direccionales - Google Patents

Reemplazo de nucleótidos por bibliotecas doblemente etiquetadas y direccionales Download PDF

Info

Publication number: ES2762866T3
Authority: ES; Spain
Prior art keywords: seq; nucleic acid; sequence; transferred; transposase
Prior art date: 2011-01-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

ES16155567T

Other languages

English (en)

Spanish (es)

Inventor

Igor Goryshin

Bradley Baas

Ramesh Vaidyanathan

Mark Maffitt

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Illumina Inc

Original Assignee

Illumina Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-01-28

Filing date

2012-01-30

Publication date

2020-05-26

2012-01-30 Application filed by Illumina Inc filed Critical Illumina Inc

2020-05-26 Application granted granted Critical

2020-05-26 Publication of ES2762866T3 publication Critical patent/ES2762866T3/es

Status Active legal-status Critical Current

2032-01-30 Anticipated expiration legal-status Critical

Links

125000003729 nucleotide group Chemical group 0.000 title description 31
239000002773 nucleotide Substances 0.000 title description 21
150000007523 nucleic acids Chemical class 0.000 claims abstract description 106
102000039446 nucleic acids Human genes 0.000 claims abstract description 102
108020004707 nucleic acids Proteins 0.000 claims abstract description 102
102000008579 Transposases Human genes 0.000 claims abstract description 40
108010020764 Transposases Proteins 0.000 claims abstract description 40
239000012634 fragment Substances 0.000 claims abstract description 39
108091034117 Oligonucleotide Proteins 0.000 claims abstract description 21
238000002372 labelling Methods 0.000 claims abstract description 18
238000006243 chemical reaction Methods 0.000 claims abstract description 14
230000000295 complement effect Effects 0.000 claims abstract description 10
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims abstract description 5
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 4
239000007801 affinity label Substances 0.000 claims description 2
239000002585 base Substances 0.000 description 58
238000000034 method Methods 0.000 description 33
238000003776 cleavage reaction Methods 0.000 description 27
230000007017 scission Effects 0.000 description 27
108020004414 DNA Proteins 0.000 description 25
-1 morpholino nucleic acid Chemical class 0.000 description 20
108090000765 processed proteins & peptides Proteins 0.000 description 11
238000012163 sequencing technique Methods 0.000 description 11
208000035657 Abasia Diseases 0.000 description 9
102000053602 DNA Human genes 0.000 description 9
239000000203 mixture Substances 0.000 description 9
102000004190 Enzymes Human genes 0.000 description 8
108090000790 Enzymes Proteins 0.000 description 8
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 8
238000012986 modification Methods 0.000 description 8
230000004048 modification Effects 0.000 description 8
108010072685 Uracil-DNA Glycosidase Proteins 0.000 description 7
102000006943 Uracil-DNA Glycosidase Human genes 0.000 description 7
210000004027 cell Anatomy 0.000 description 7
238000003752 polymerase chain reaction Methods 0.000 description 7
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
108010042407 Endonucleases Proteins 0.000 description 6
102000004533 Endonucleases Human genes 0.000 description 6
GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 6
101710163270 Nuclease Proteins 0.000 description 6
108091093037 Peptide nucleic acid Proteins 0.000 description 6
108010012306 Tn5 transposase Proteins 0.000 description 6
239000000126 substance Substances 0.000 description 6
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 5
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 5
229960002685 biotin Drugs 0.000 description 5
239000011616 biotin Substances 0.000 description 5
239000005547 deoxyribonucleotide Substances 0.000 description 5
125000002637 deoxyribonucleotide group Chemical group 0.000 description 5
238000013467 fragmentation Methods 0.000 description 5
238000006062 fragmentation reaction Methods 0.000 description 5
150000003013 phosphoric acid derivatives Chemical class 0.000 description 5
102000040430 polynucleotide Human genes 0.000 description 5
108091033319 polynucleotide Proteins 0.000 description 5
239000002157 polynucleotide Substances 0.000 description 5
102000010719 DNA-(Apurinic or Apyrimidinic Site) Lyase Human genes 0.000 description 4
108010063362 DNA-(Apurinic or Apyrimidinic Site) Lyase Proteins 0.000 description 4
108010000577 DNA-Formamidopyrimidine Glycosylase Proteins 0.000 description 4
108091028043 Nucleic acid sequence Proteins 0.000 description 4
108091028664 Ribonucleotide Proteins 0.000 description 4
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
102000023732 binding proteins Human genes 0.000 description 4
108091008324 binding proteins Proteins 0.000 description 4
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
239000000975 dye Substances 0.000 description 4
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 4
DRAVOWXCEBXPTN-UHFFFAOYSA-N isoguanine Chemical class NC1=NC(=O)NC2=C1NC=N2 DRAVOWXCEBXPTN-UHFFFAOYSA-N 0.000 description 4
229910052757 nitrogen Inorganic materials 0.000 description 4
125000006239 protecting group Chemical group 0.000 description 4
238000011160 research Methods 0.000 description 4
239000002336 ribonucleotide Substances 0.000 description 4
125000002652 ribonucleotide group Chemical group 0.000 description 4
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 4
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
229940035893 uracil Drugs 0.000 description 4
108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
UBKVUFQGVWHZIR-UHFFFAOYSA-N 8-oxoguanine Chemical compound O=C1NC(N)=NC2=NC(=O)N=C21 UBKVUFQGVWHZIR-UHFFFAOYSA-N 0.000 description 3
102000012410 DNA Ligases Human genes 0.000 description 3
108010061982 DNA Ligases Proteins 0.000 description 3
108010008532 Deoxyribonuclease I Proteins 0.000 description 3
102000007260 Deoxyribonuclease I Human genes 0.000 description 3
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
108091081062 Repeated sequence (DNA) Proteins 0.000 description 3
229960000643 adenine Drugs 0.000 description 3
230000003321 amplification Effects 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
235000020958 biotin Nutrition 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
239000002299 complementary DNA Substances 0.000 description 3
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 3
238000003780 insertion Methods 0.000 description 3
230000037431 insertion Effects 0.000 description 3
239000003068 molecular probe Substances 0.000 description 3
238000003199 nucleic acid amplification method Methods 0.000 description 3
MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 3
RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 2
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 2
XQCZBXHVTFVIFE-UHFFFAOYSA-N 2-amino-4-hydroxypyrimidine Chemical class NC1=NC=CC(O)=N1 XQCZBXHVTFVIFE-UHFFFAOYSA-N 0.000 description 2
FZWGECJQACGGTI-UHFFFAOYSA-N 2-amino-7-methyl-1,7-dihydro-6H-purin-6-one Chemical compound NC1=NC(O)=C2N(C)C=NC2=N1 FZWGECJQACGGTI-UHFFFAOYSA-N 0.000 description 2
GYMFBYTZOGMSQJ-UHFFFAOYSA-N 2-methylanthracene Chemical compound C1=CC=CC2=CC3=CC(C)=CC=C3C=C21 GYMFBYTZOGMSQJ-UHFFFAOYSA-N 0.000 description 2
LOJNBPNACKZWAI-UHFFFAOYSA-N 3-nitro-1h-pyrrole Chemical compound [O-][N+](=O)C=1C=CNC=1 LOJNBPNACKZWAI-UHFFFAOYSA-N 0.000 description 2
OZFPSOBLQZPIAV-UHFFFAOYSA-N 5-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2NC=CC2=C1 OZFPSOBLQZPIAV-UHFFFAOYSA-N 0.000 description 2
RGKBRPAAQSHTED-UHFFFAOYSA-N 8-oxoadenine Chemical compound NC1=NC=NC2=C1NC(=O)N2 RGKBRPAAQSHTED-UHFFFAOYSA-N 0.000 description 2
MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 2
229930024421 Adenine Natural products 0.000 description 2
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 2
108010001336 Horseradish Peroxidase Proteins 0.000 description 2
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 2
SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
229930010555 Inosine Natural products 0.000 description 2
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 2
102000003960 Ligases Human genes 0.000 description 2
108090000364 Ligases Proteins 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
108010090804 Streptavidin Proteins 0.000 description 2
RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 2
239000002253 acid Substances 0.000 description 2
239000003513 alkali Substances 0.000 description 2
230000000692 anti-sense effect Effects 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
235000014633 carbohydrates Nutrition 0.000 description 2
238000007385 chemical modification Methods 0.000 description 2
229940104302 cytosine Drugs 0.000 description 2
MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 description 2
QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 2
SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 2
NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 2
QRMZSPFSDQBLIX-UHFFFAOYSA-N homovanillic acid Chemical compound COC1=CC(CC(O)=O)=CC=C1O QRMZSPFSDQBLIX-UHFFFAOYSA-N 0.000 description 2
238000009396 hybridization Methods 0.000 description 2
229960003786 inosine Drugs 0.000 description 2
DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 2
229910021645 metal ion Inorganic materials 0.000 description 2
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
150000002972 pentoses Chemical class 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
230000037452 priming Effects 0.000 description 2
230000008569 process Effects 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
239000002096 quantum dot Substances 0.000 description 2
229910052761 rare earth metal Inorganic materials 0.000 description 2
108091008146 restriction endonucleases Proteins 0.000 description 2
229960003471 retinol Drugs 0.000 description 2
235000020944 retinol Nutrition 0.000 description 2
239000011607 retinol Substances 0.000 description 2
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
239000011734 sodium Substances 0.000 description 2
JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
239000000243 solution Substances 0.000 description 2
241000894007 species Species 0.000 description 2
230000003595 spectral effect Effects 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
229940113082 thymine Drugs 0.000 description 2
PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 2
XSYUPRQVAHJETO-WPMUBMLPSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidaz Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 XSYUPRQVAHJETO-WPMUBMLPSA-N 0.000 description 1
NZDOXVCRXDAVII-UHFFFAOYSA-N 1-[4-(1h-benzimidazol-2-yl)phenyl]pyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1=CC=C(C=2NC3=CC=CC=C3N=2)C=C1 NZDOXVCRXDAVII-UHFFFAOYSA-N 0.000 description 1
ADEORFBTPGKHRP-UHFFFAOYSA-N 1-[7-(dimethylamino)-4-methyl-2-oxochromen-3-yl]pyrrole-2,5-dione Chemical compound O=C1OC2=CC(N(C)C)=CC=C2C(C)=C1N1C(=O)C=CC1=O ADEORFBTPGKHRP-UHFFFAOYSA-N 0.000 description 1
TZMSYXZUNZXBOL-UHFFFAOYSA-N 10H-phenoxazine Chemical compound C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 description 1
VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 1
SCSMTGPIQWEYHG-UHFFFAOYSA-N 2,4-diphenylfuran-3-one Chemical compound O=C1C(C=2C=CC=CC=2)OC=C1C1=CC=CC=C1 SCSMTGPIQWEYHG-UHFFFAOYSA-N 0.000 description 1
GIMRVVLNBSNCLO-UHFFFAOYSA-N 2,6-diamino-5-formamido-4-hydroxypyrimidine Chemical compound NC1=NC(=O)C(NC=O)C(N)=N1 GIMRVVLNBSNCLO-UHFFFAOYSA-N 0.000 description 1
RDVCCJOZVDOCSX-UHFFFAOYSA-N 2-(2-aminoethylamino)acetamide Chemical group NCCNCC(N)=O RDVCCJOZVDOCSX-UHFFFAOYSA-N 0.000 description 1
FXOFHRIXQOZXNZ-UHFFFAOYSA-N 2-aminoethyl 2,3-dihydroxypropyl hydrogen phosphate;5-(dimethylamino)naphthalene-1-sulfonic acid Chemical compound NCCOP(O)(=O)OCC(O)CO.C1=CC=C2C(N(C)C)=CC=CC2=C1S(O)(=O)=O FXOFHRIXQOZXNZ-UHFFFAOYSA-N 0.000 description 1
WWVANQJRLPIHNS-BKPPORCPSA-N 2-iminobiotin Chemical compound N1C(=N)N[C@H]2[C@H](CCCCC(=O)O)SC[C@H]21 WWVANQJRLPIHNS-BKPPORCPSA-N 0.000 description 1
IUYOQSNYOMNIBJ-UHFFFAOYSA-N 2-methyl-4-[4-(2-methyl-5-phenyl-1,3-oxazol-4-yl)phenyl]-5-phenyl-1,3-oxazole Chemical compound CC=1OC(=C(N=1)C1=CC=C(C=C1)C=1N=C(OC=1C1=CC=CC=C1)C)C1=CC=CC=C1 IUYOQSNYOMNIBJ-UHFFFAOYSA-N 0.000 description 1
JBIJLHTVPXGSAM-UHFFFAOYSA-N 2-naphthylamine Chemical compound C1=CC=CC2=CC(N)=CC=C21 JBIJLHTVPXGSAM-UHFFFAOYSA-N 0.000 description 1
HCGYMSSYSAKGPK-UHFFFAOYSA-N 2-nitro-1h-indole Chemical compound C1=CC=C2NC([N+](=O)[O-])=CC2=C1 HCGYMSSYSAKGPK-UHFFFAOYSA-N 0.000 description 1
FTBBGQKRYUTLMP-UHFFFAOYSA-N 2-nitro-1h-pyrrole Chemical compound [O-][N+](=O)C1=CC=CN1 FTBBGQKRYUTLMP-UHFFFAOYSA-N 0.000 description 1
OALHHIHQOFIMEF-UHFFFAOYSA-N 3',6'-dihydroxy-2',4',5',7'-tetraiodo-3h-spiro[2-benzofuran-1,9'-xanthene]-3-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 OALHHIHQOFIMEF-UHFFFAOYSA-N 0.000 description 1
BNZPZVPHQDLRKJ-UHFFFAOYSA-N 3-[bis(2-carboxyethoxy)phosphoryloxy]propanoic acid;hydrochloride Chemical compound Cl.OC(=O)CCOP(=O)(OCCC(O)=O)OCCC(O)=O BNZPZVPHQDLRKJ-UHFFFAOYSA-N 0.000 description 1
IGHBXJSNZCFXNK-UHFFFAOYSA-N 4-chloro-7-nitrobenzofurazan Chemical compound [O-][N+](=O)C1=CC=C(Cl)C2=NON=C12 IGHBXJSNZCFXNK-UHFFFAOYSA-N 0.000 description 1
XORHNJQEWQGXCN-UHFFFAOYSA-N 4-nitro-1h-pyrazole Chemical compound [O-][N+](=O)C=1C=NNC=1 XORHNJQEWQGXCN-UHFFFAOYSA-N 0.000 description 1
NWQCTCKWUOEREG-UHFFFAOYSA-N 5-(2-methylanilino)naphthalene-2-sulfonic acid Chemical compound CC1=CC=CC=C1NC1=CC=CC2=CC(S(O)(=O)=O)=CC=C12 NWQCTCKWUOEREG-UHFFFAOYSA-N 0.000 description 1
OFJNVANOCZHTMW-UHFFFAOYSA-N 5-hydroxyuracil Chemical compound OC1=CNC(=O)NC1=O OFJNVANOCZHTMW-UHFFFAOYSA-N 0.000 description 1
LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical group CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
VYDWQPKRHOGLPA-UHFFFAOYSA-N 5-nitroimidazole Chemical compound [O-][N+](=O)C1=CN=CN1 VYDWQPKRHOGLPA-UHFFFAOYSA-N 0.000 description 1
MGKOJZBNNSRXRO-UHFFFAOYSA-N 6-(n-methylanilino)naphthalene-2-sulfonic acid Chemical compound C=1C=C2C=C(S(O)(=O)=O)C=CC2=CC=1N(C)C1=CC=CC=C1 MGKOJZBNNSRXRO-UHFFFAOYSA-N 0.000 description 1
NLLCDONDZDHLCI-UHFFFAOYSA-N 6-amino-5-hydroxy-1h-pyrimidin-2-one Chemical compound NC=1NC(=O)N=CC=1O NLLCDONDZDHLCI-UHFFFAOYSA-N 0.000 description 1
DTFZXNJFEIZTJR-UHFFFAOYSA-N 6-anilinonaphthalene-2-sulfonic acid Chemical compound C1=CC2=CC(S(=O)(=O)O)=CC=C2C=C1NC1=CC=CC=C1 DTFZXNJFEIZTJR-UHFFFAOYSA-N 0.000 description 1
MPVDXIMFBOLMNW-ISLYRVAYSA-N 7-hydroxy-8-[(E)-phenyldiazenyl]naphthalene-1,3-disulfonic acid Chemical compound OC1=CC=C2C=C(S(O)(=O)=O)C=C(S(O)(=O)=O)C2=C1\N=N\C1=CC=CC=C1 MPVDXIMFBOLMNW-ISLYRVAYSA-N 0.000 description 1
CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
FWEOQOXTVHGIFQ-UHFFFAOYSA-N 8-anilinonaphthalene-1-sulfonic acid Chemical compound C=12C(S(=O)(=O)O)=CC=CC2=CC=CC=1NC1=CC=CC=C1 FWEOQOXTVHGIFQ-UHFFFAOYSA-N 0.000 description 1
150000005027 9-aminoacridines Chemical group 0.000 description 1
OGOYZCQQQFAGRI-UHFFFAOYSA-N 9-ethenylanthracene Chemical compound C1=CC=C2C(C=C)=C(C=CC=C3)C3=CC2=C1 OGOYZCQQQFAGRI-UHFFFAOYSA-N 0.000 description 1
GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
241000589158 Agrobacterium Species 0.000 description 1
239000012099 Alexa Fluor family Substances 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
108700028369 Alleles Proteins 0.000 description 1
108091093088 Amplicon Proteins 0.000 description 1
108091023037 Aptamer Proteins 0.000 description 1
241000203069 Archaea Species 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
241000589968 Borrelia Species 0.000 description 1
241000244203 Caenorhabditis elegans Species 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
241000606161 Chlamydia Species 0.000 description 1
108020004998 Chloroplast DNA Proteins 0.000 description 1
241000193403 Clostridium Species 0.000 description 1
241001137853 Crenarchaeota Species 0.000 description 1
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
108020001738 DNA Glycosylase Proteins 0.000 description 1
108010017826 DNA Polymerase I Proteins 0.000 description 1
102000004594 DNA Polymerase I Human genes 0.000 description 1
230000004544 DNA amplification Effects 0.000 description 1
102000028381 DNA glycosylase Human genes 0.000 description 1
XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 1
108010036364 Deoxyribonuclease IV (Phage T4-Induced) Proteins 0.000 description 1
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
108010067770 Endopeptidase K Proteins 0.000 description 1
241000588698 Erwinia Species 0.000 description 1
241000588722 Escherichia Species 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
241000206602 Eukaryota Species 0.000 description 1
229910052693 Europium Inorganic materials 0.000 description 1
241000233866 Fungi Species 0.000 description 1
108091093094 Glycol nucleic acid Proteins 0.000 description 1
241000589989 Helicobacter Species 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
102000012330 Integrases Human genes 0.000 description 1
108010061833 Integrases Proteins 0.000 description 1
241000589248 Legionella Species 0.000 description 1
208000007764 Legionnaires' Disease Diseases 0.000 description 1
208000016604 Lyme disease Diseases 0.000 description 1
PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
108020005196 Mitochondrial DNA Proteins 0.000 description 1
241000186359 Mycobacterium Species 0.000 description 1
241000204031 Mycoplasma Species 0.000 description 1
UCIRZXAGRBPGJM-UHFFFAOYSA-N NC1=CC=CN=C1.NC1=CC=CN=C1.ICCCCCCCCCCI Chemical compound NC1=CC=CN=C1.NC1=CC=CN=C1.ICCCCCCCCCCI UCIRZXAGRBPGJM-UHFFFAOYSA-N 0.000 description 1
241001437658 Nanoarchaeota Species 0.000 description 1
241000588653 Neisseria Species 0.000 description 1
241000244206 Nematoda Species 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108010004729 Phycoerythrin Proteins 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
102000001253 Protein Kinase Human genes 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
229930185560 Pseudouridine Natural products 0.000 description 1
PTJWIQPHWPFNBW-UHFFFAOYSA-N Pseudouridine C Natural products OC1C(O)C(CO)OC1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-UHFFFAOYSA-N 0.000 description 1
241000700159 Rattus Species 0.000 description 1
241000589180 Rhizobium Species 0.000 description 1
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
240000008254 Rosa chinensis Species 0.000 description 1
235000000664 Rosa chinensis Nutrition 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
241000607720 Serratia Species 0.000 description 1
241000191940 Staphylococcus Species 0.000 description 1
241000191967 Staphylococcus aureus Species 0.000 description 1
PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
241000194017 Streptococcus Species 0.000 description 1
241000187747 Streptomyces Species 0.000 description 1
ODJLBQGVINUMMR-UHFFFAOYSA-N Strophanthidin Natural products CC12CCC(C3(CCC(O)CC3(O)CC3)C=O)C3C1(O)CCC2C1=CC(=O)OC1 ODJLBQGVINUMMR-UHFFFAOYSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
241000205091 Sulfolobus solfataricus Species 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
229910052771 Terbium Inorganic materials 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
241000589886 Treponema Species 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
108010020713 Tth polymerase Proteins 0.000 description 1
CPGKMLVTFNUAHL-UHFFFAOYSA-N [Ca].[Ca] Chemical compound [Ca].[Ca] CPGKMLVTFNUAHL-UHFFFAOYSA-N 0.000 description 1
DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
150000001241 acetals Chemical class 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 description 1
PPQRONHOSHZGFQ-LMVFSUKVSA-N aldehydo-D-ribose 5-phosphate Chemical group OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PPQRONHOSHZGFQ-LMVFSUKVSA-N 0.000 description 1
125000003545 alkoxy group Chemical group 0.000 description 1
125000003282 alkyl amino group Chemical group 0.000 description 1
125000005336 allyloxy group Chemical group 0.000 description 1
125000003275 alpha amino acid group Chemical group 0.000 description 1
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
150000001454 anthracenes Chemical class 0.000 description 1
239000000427 antigen Substances 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
238000013459 approach Methods 0.000 description 1
238000003556 assay Methods 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
239000011324 bead Substances 0.000 description 1
WGDUUQDYDIIBKT-UHFFFAOYSA-N beta-Pseudouridine Natural products OC1OC(CN2C=CC(=O)NC2=O)C(O)C1O WGDUUQDYDIIBKT-UHFFFAOYSA-N 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
125000001246 bromo group Chemical group Br* 0.000 description 1
108010043595 captavidin Proteins 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000013043 chemical agent Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003638 chemical reducing agent Substances 0.000 description 1
125000001309 chloro group Chemical group Cl* 0.000 description 1
CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
230000000536 complexating effect Effects 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
VGONTNSXDCQUGY-UHFFFAOYSA-N desoxyinosine Natural products C1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 VGONTNSXDCQUGY-UHFFFAOYSA-N 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
PGUYAANYCROBRT-UHFFFAOYSA-N dihydroxy-selanyl-selanylidene-lambda5-phosphane Chemical compound OP(O)([SeH])=[Se] PGUYAANYCROBRT-UHFFFAOYSA-N 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
125000002228 disulfide group Chemical group 0.000 description 1
238000000835 electrochemical detection Methods 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
229940011411 erythrosine Drugs 0.000 description 1
235000012732 erythrosine Nutrition 0.000 description 1
239000004174 erythrosine Substances 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
125000001153 fluoro group Chemical group F* 0.000 description 1
230000004927 fusion Effects 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
102000054766 genetic haplotypes Human genes 0.000 description 1
239000011521 glass Substances 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
229910001385 heavy metal Inorganic materials 0.000 description 1
125000000623 heterocyclic group Chemical group 0.000 description 1
IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
229920001519 homopolymer Polymers 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
150000002466 imines Chemical class 0.000 description 1
PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
229910052747 lanthanoid Inorganic materials 0.000 description 1
150000002602 lanthanoids Chemical class 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 1
239000003446 ligand Substances 0.000 description 1
DLBFLQKQABVKGT-UHFFFAOYSA-L lucifer yellow dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(C(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N DLBFLQKQABVKGT-UHFFFAOYSA-L 0.000 description 1
UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
239000011654 magnesium acetate Substances 0.000 description 1
229940069446 magnesium acetate Drugs 0.000 description 1
235000011285 magnesium acetate Nutrition 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
239000006249 magnetic particle Substances 0.000 description 1
FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 1
229940107698 malachite green Drugs 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000003550 marker Substances 0.000 description 1
239000000463 material Substances 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
230000002438 mitochondrial effect Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
239000000178 monomer Substances 0.000 description 1
125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
108010009127 mu transposase Proteins 0.000 description 1
KVKFRMCSXWQSNT-UHFFFAOYSA-N n,n'-dimethylethane-1,2-diamine Chemical compound CNCCNC KVKFRMCSXWQSNT-UHFFFAOYSA-N 0.000 description 1
VRBDBUHDIOJNGW-UHFFFAOYSA-N n,n-dimethylnaphtho[2,3-h]cinnolin-6-amine Chemical compound C1=CC=C2C=C3C(N(C)C)=CC4=CC=NN=C4C3=CC2=C1 VRBDBUHDIOJNGW-UHFFFAOYSA-N 0.000 description 1
OUAAURDVPDKVAK-UHFFFAOYSA-N n-phenyl-1h-benzimidazol-2-amine Chemical compound N=1C2=CC=CC=C2NC=1NC1=CC=CC=C1 OUAAURDVPDKVAK-UHFFFAOYSA-N 0.000 description 1
239000002159 nanocrystal Substances 0.000 description 1
IHRUNHAGYIHWNV-UHFFFAOYSA-N naphtho[2,3-h]cinnoline Chemical compound C1=NN=C2C3=CC4=CC=CC=C4C=C3C=CC2=C1 IHRUNHAGYIHWNV-UHFFFAOYSA-N 0.000 description 1
239000006199 nebulizer Substances 0.000 description 1
239000013642 negative control Substances 0.000 description 1
108010087904 neutravidin Proteins 0.000 description 1
238000007481 next generation sequencing Methods 0.000 description 1
229910052759 nickel Inorganic materials 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
125000003835 nucleoside group Chemical group 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
210000003463 organelle Anatomy 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
125000004430 oxygen atom Chemical group O* 0.000 description 1
244000045947 parasite Species 0.000 description 1
KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 1
CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 1
RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical group C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 1
125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoramidic acid Chemical compound NP(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 description 1
150000008300 phosphoramidites Chemical class 0.000 description 1
125000004437 phosphorous atom Chemical group 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
229920000768 polyamine Polymers 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
150000004032 porphyrins Chemical class 0.000 description 1
239000013641 positive control Substances 0.000 description 1
235000011056 potassium acetate Nutrition 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
108060006633 protein kinase Proteins 0.000 description 1
PTJWIQPHWPFNBW-GBNDHIKLSA-N pseudouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-GBNDHIKLSA-N 0.000 description 1
DLOBKMWCBFOUHP-UHFFFAOYSA-N pyrene-1-sulfonic acid Chemical compound C1=C2C(S(=O)(=O)O)=CC=C(C=C3)C2=C2C3=CC=CC2=C1 DLOBKMWCBFOUHP-UHFFFAOYSA-N 0.000 description 1
150000003220 pyrenes Chemical class 0.000 description 1
HBCQSNAFLVXVAY-UHFFFAOYSA-N pyrimidine-2-thiol Chemical compound SC1=NC=CC=N1 HBCQSNAFLVXVAY-UHFFFAOYSA-N 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
150000002910 rare earth metals Chemical class 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
238000006462 rearrangement reaction Methods 0.000 description 1
HSSLDCABUXLXKM-UHFFFAOYSA-N resorufin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3N=C21 HSSLDCABUXLXKM-UHFFFAOYSA-N 0.000 description 1
AZJPTIGZZTZIDR-UHFFFAOYSA-L rose bengal Chemical compound [K+].[K+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 AZJPTIGZZTZIDR-UHFFFAOYSA-L 0.000 description 1
239000000523 sample Substances 0.000 description 1
JRPHGDYSKGJTKZ-UHFFFAOYSA-K selenophosphate Chemical compound [O-]P([O-])([O-])=[Se] JRPHGDYSKGJTKZ-UHFFFAOYSA-K 0.000 description 1
239000004054 semiconductor nanocrystal Substances 0.000 description 1
238000000926 separation method Methods 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
OSQUFVVXNRMSHL-LTHRDKTGSA-M sodium;3-[(2z)-2-[(e)-4-(1,3-dibutyl-4,6-dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene)but-2-enylidene]-1,3-benzoxazol-3-yl]propane-1-sulfonate Chemical compound [Na+].O=C1N(CCCC)C(=S)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 OSQUFVVXNRMSHL-LTHRDKTGSA-M 0.000 description 1
PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
235000021286 stilbenes Nutrition 0.000 description 1
239000012089 stop solution Substances 0.000 description 1
ODJLBQGVINUMMR-HZXDTFASSA-N strophanthidin Chemical compound C1([C@H]2CC[C@]3(O)[C@H]4[C@@H]([C@]5(CC[C@H](O)C[C@@]5(O)CC4)C=O)CC[C@@]32C)=CC(=O)OC1 ODJLBQGVINUMMR-HZXDTFASSA-N 0.000 description 1
239000000758 substrate Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
230000008685 targeting Effects 0.000 description 1
GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
150000007970 thio esters Chemical group 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
229910052723 transition metal Inorganic materials 0.000 description 1
150000003624 transition metals Chemical class 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
230000003612 virological effect Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1065—Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
- C12Q1/6855—Ligating adaptors
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Crystallography & Structural Chemistry (AREA)
Plant Pathology (AREA)
Bioinformatics & Computational Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Analytical Chemistry (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

ES16155567T 2011-01-28 2012-01-30 Reemplazo de nucleótidos por bibliotecas doblemente etiquetadas y direccionales Active ES2762866T3 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201161437451P	2011-01-28	2011-01-28
US201161506777P	2011-07-12	2011-07-12

Publications (1)

Publication Number	Publication Date
ES2762866T3 true ES2762866T3 (es)	2020-05-26

Family

ID=45809570

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
ES16155567T Active ES2762866T3 (es)	2011-01-28	2012-01-30	Reemplazo de nucleótidos por bibliotecas doblemente etiquetadas y direccionales
ES12707675.0T Active ES2568910T3 (es)	2011-01-28	2012-01-30	Reemplazo de oligonucleótidos para bibliotecas etiquetadas en dos extremos y direccionadas

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
ES12707675.0T Active ES2568910T3 (es)	2011-01-28	2012-01-30	Reemplazo de oligonucleótidos para bibliotecas etiquetadas en dos extremos y direccionadas

Country Status (7)

Country	Link
US (4)	US9238671B2 (fr)
EP (2)	EP2668273B9 (fr)
AU (1)	AU2012211081B2 (fr)
CA (1)	CA2821559C (fr)
DK (2)	DK2668273T3 (fr)
ES (2)	ES2762866T3 (fr)
WO (1)	WO2012103545A1 (fr)

Families Citing this family (106)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2573562A3 (fr)	2007-02-09	2013-10-30	Advanced Liquid Logic, Inc.	Dispositifs actionneurs de gouttelettes et procédés utilisant des billes magnétiques
US8383345B2 (en)	2008-09-12	2013-02-26	University Of Washington	Sequence tag directed subassembly of short sequencing reads into long sequencing reads
WO2010086622A1 (fr)	2009-01-30	2010-08-05	Oxford Nanopore Technologies Limited	Adaptateurs pour des constructions d'acide nucléique dans le séquençage de séquences transmembranaires
US9074251B2 (en)	2011-02-10	2015-07-07	Illumina, Inc.	Linking sequence reads using paired code tags
WO2012103545A1 (fr) *	2011-01-28	2012-08-02	Illumina, Inc.	Remplacement d'oligonucléotides pour bibliothèques marquées aux deux extrémités et directionnelles
WO2012106546A2 (fr)	2011-02-02	2012-08-09	University Of Washington Through Its Center For Commercialization	Cartographie massivement parallèle de contiguïté
IN2014DN00221A (fr)	2011-07-25	2015-06-05	Oxford Nanopore Tech Ltd
NO2694769T3 (fr) *	2012-03-06	2018-03-03
WO2014013259A1 (fr)	2012-07-19	2014-01-23	Oxford Nanopore Technologies Limited	Procédé ssb
US10323279B2 (en)	2012-08-14	2019-06-18	10X Genomics, Inc.	Methods and systems for processing polynucleotides
US10584381B2 (en)	2012-08-14	2020-03-10	10X Genomics, Inc.	Methods and systems for processing polynucleotides
US9701998B2 (en)	2012-12-14	2017-07-11	10X Genomics, Inc.	Methods and systems for processing polynucleotides
US10221442B2 (en)	2012-08-14	2019-03-05	10X Genomics, Inc.	Compositions and methods for sample processing
US11591637B2 (en)	2012-08-14	2023-02-28	10X Genomics, Inc.	Compositions and methods for sample processing
US9951386B2 (en)	2014-06-26	2018-04-24	10X Genomics, Inc.	Methods and systems for processing polynucleotides
US10752949B2 (en)	2012-08-14	2020-08-25	10X Genomics, Inc.	Methods and systems for processing polynucleotides
US10273541B2 (en)	2012-08-14	2019-04-30	10X Genomics, Inc.	Methods and systems for processing polynucleotides
JP6367196B2 (ja)	2012-08-14	2018-08-01	テンエックス・ジェノミクス・インコーポレイテッド	マイクロカプセル組成物および方法
US10533221B2 (en)	2012-12-14	2020-01-14	10X Genomics, Inc.	Methods and systems for processing polynucleotides
EP3567116A1 (fr)	2012-12-14	2019-11-13	10X Genomics, Inc.	Procédés et systèmes de traitement de polynucléotides
US9683230B2 (en)	2013-01-09	2017-06-20	Illumina Cambridge Limited	Sample preparation on a solid support
KR102190198B1 (ko)	2013-02-08	2020-12-14	10엑스 제노믹스, 인크.	폴리뉴클레오티드 바코드 생성
BR112015021788B1 (pt)	2013-03-08	2023-02-28	Oxford Nanopore Technologies Plc	Métodos para mover uma ou mais helicases imobilizadas, para controlar o movimento de um polinucleotídeo alvo, para caracterizar um polinucleotídeo alvo e para controlar o carregamento de uma ou mais helicases em um polinucleotídeo alvo, uso de um poro de transmembrana e de um potencial aplicado e de um ou mais espaçadores, complexo, e, kit
GB201314695D0 (en)	2013-08-16	2013-10-02	Oxford Nanopore Tech Ltd	Method
EP3553175B1 (fr) *	2013-03-13	2021-07-14	Illumina, Inc.	Procédé de préparation d'une banque de séquençage d'acides nucléiques
EP4617376A3 (fr)	2013-05-23	2025-12-10	The Board of Trustees of the Leland Stanford Junior University	Transposition en chromatine native pour l'épigénomique personnelle
US10266894B2 (en)	2013-08-23	2019-04-23	Ludwig Institute For Cancer Research Ltd	Methods and compositions for cDNA synthesis and single-cell transcriptome profiling using template switching reaction
US10415083B2 (en)	2013-10-28	2019-09-17	The Translational Genomics Research Institute	Long insert-based whole genome sequencing
EP3066114B1 (fr) *	2013-11-07	2019-11-13	Agilent Technologies, Inc.	Pluralité d'adaptateurs de transposase destinés à des manipulations d'adn
US10246746B2 (en)	2013-12-20	2019-04-02	Illumina, Inc.	Preserving genomic connectivity information in fragmented genomic DNA samples
JP6525342B2 (ja) *	2014-01-14	2019-06-05	キアゲンゲーエムベーハー	タグ付けされたｄｎａ断片の生成
EP3105349B1 (fr)	2014-02-11	2020-07-15	F. Hoffmann-La Roche AG	Séquençage ciblé et filtrage uid
GB201403096D0 (en)	2014-02-21	2014-04-09	Oxford Nanopore Tech Ltd	Sample preparation method
CA2943624A1 (fr)	2014-04-10	2015-10-15	10X Genomics, Inc.	Dispositifs fluidiques, systemes et procedes permettant d'encapsuler et de separer des reactifs, et leurs applications
EP4574974A3 (fr)	2014-06-26	2025-10-08	10x Genomics, Inc.	Procédés d'analyse d'acides nucléiques à partir de cellules individuelles ou de populations cellulaires
US12312640B2 (en)	2014-06-26	2025-05-27	10X Genomics, Inc.	Analysis of nucleic acid sequences
WO2015200869A1 (fr)	2014-06-26	2015-12-30	10X Genomics, Inc.	Analyse de séquences d'acides nucléiques
WO2016003814A1 (fr) *	2014-06-30	2016-01-07	Illumina, Inc.	Méthodes et compositions utilisant une transposition unilatérale
CN106715713B (zh) *	2014-09-12	2020-11-03	深圳华大智造科技有限公司	试剂盒及其在核酸测序中的用途
US10040048B1 (en)	2014-09-25	2018-08-07	Synthego Corporation	Automated modular system and method for production of biopolymers
GB201418159D0 (en)	2014-10-14	2014-11-26	Oxford Nanopore Tech Ltd	Method
US20170292153A1 (en) *	2014-10-14	2017-10-12	Bgi Shenzhen Co., Limited	Method for breaking nucleic acid and adding adaptor by means of transposase, and reagent
JP6808617B2 (ja)	2014-10-17	2021-01-06	イルミナケンブリッジリミテッド	連続性を維持した転位
CN114045282B (zh) *	2014-10-17	2025-03-07	伊卢米纳剑桥有限公司	接近性保留性转座
CA2965485A1 (fr) *	2014-10-21	2016-04-28	Martin R. Schiller	Procedes et compositions permettant le depistage de fonction moleculaire comprenant des mini-motifs chimeriques
WO2016069939A1 (fr)	2014-10-29	2016-05-06	10X Genomics, Inc.	Procédés et compositions de séquençage ciblé d'acides nucléiques
US9975122B2 (en)	2014-11-05	2018-05-22	10X Genomics, Inc.	Instrument systems for integrated sample processing
US10900065B2 (en)	2014-11-14	2021-01-26	University Of Washington	Methods and kits for labeling cellular molecules
CN107427808B (zh)	2015-01-12	2020-10-23	10X基因组学有限公司	用于制备核酸测序文库的方法和系统以及用其制备的文库
EP3262407B1 (fr)	2015-02-24	2023-08-30	10X Genomics, Inc.	Procédés et systèmes de traitement de cloisonnement
CN107532202A (zh)	2015-02-24	2018-01-02	10X 基因组学有限公司	用于靶向核酸序列覆盖的方法
JP6698708B2 (ja)	2015-06-09	2020-05-27	ライフテクノロジーズコーポレーション	分子タグ付けのための方法、システム、組成物、キット、装置、及びコンピュータ可読媒体
US9771575B2 (en)	2015-06-19	2017-09-26	Agilent Technologies, Inc.	Methods for on-array fragmentation and barcoding of DNA samples
WO2017004083A1 (fr) *	2015-06-29	2017-01-05	The Regents Of The University Of California	Procédés de production de bibliothèques d'acides nucléiques et compositions et kits pour la pratique de ceux-ci
SI3334841T1 (sl)	2015-08-12	2020-03-31	Cemm - Forschungszentrum Fuer Molekulare Medizin Gmbh	Postopki za proučevanje nukleinskih kislin
SG10202108763UA (en)	2015-12-04	2021-09-29	10X Genomics Inc	Methods and compositions for nucleic acid analysis
US10160987B2 (en)	2016-04-07	2018-12-25	Rebecca F. McClure	Composition and method for processing DNA
WO2017184691A1 (fr) *	2016-04-19	2017-10-26	Kapa Biosystems, Inc.	Système de contrôle d'un compétiteur de transposase
WO2017197343A2 (fr)	2016-05-12	2017-11-16	10X Genomics, Inc.	Filtres microfluidiques sur puce
WO2017197338A1 (fr)	2016-05-13	2017-11-16	10X Genomics, Inc.	Systèmes microfluidiques et procédés d'utilisation
GB201609220D0 (en)	2016-05-25	2016-07-06	Oxford Nanopore Tech Ltd	Method
WO2018013724A1 (fr) *	2016-07-12	2018-01-18	Kapa Biosystems, Inc.	Système et procédé de séquençage d'amplicon médié par une transposase
WO2018013710A1 (fr)	2016-07-12	2018-01-18	F. Hoffman-La Roche Ag	Enrichissement de cible d'extension d'amorce
WO2018027048A1 (fr)	2016-08-05	2018-02-08	Bio-Rad Laboratories, Inc.	Protocle direct avec un second brin
JP6941680B2 (ja)	2016-10-24	2021-09-29	ジェネインフォセック、インコーポレイテッド	核酸内に存在する情報の秘匿化
WO2018118971A1 (fr)	2016-12-19	2018-06-28	Bio-Rad Laboratories, Inc.	Adn marqué ayant une contiguïté préservée de marquage par gouttelettes
US10011872B1 (en)	2016-12-22	2018-07-03	10X Genomics, Inc.	Methods and systems for processing polynucleotides
US10550429B2 (en)	2016-12-22	2020-02-04	10X Genomics, Inc.	Methods and systems for processing polynucleotides
US10815525B2 (en)	2016-12-22	2020-10-27	10X Genomics, Inc.	Methods and systems for processing polynucleotides
EP4310183B1 (fr)	2017-01-30	2025-07-09	10X Genomics, Inc.	Procédés et systèmes de codage à barres de cellules uniques à base de gouttelettes
US12264411B2 (en)	2017-01-30	2025-04-01	10X Genomics, Inc.	Methods and systems for analysis
FI3452621T3 (fi)	2017-02-21	2022-12-15		Tagmentaatio käyttäen immobilisoituja transposomeja linkkereillä
JP7056012B2 (ja) *	2017-05-19	2022-04-19	トヨタ自動車株式会社	ランダムプライマーセット、及びこれを用いたｄｎａライブラリーの作製方法
CN109526228B (zh)	2017-05-26	2022-11-25	10X基因组学有限公司	转座酶可接近性染色质的单细胞分析
US10844372B2 (en)	2017-05-26	2020-11-24	10X Genomics, Inc.	Single cell analysis of transposase accessible chromatin
US20190076814A1 (en)	2017-09-11	2019-03-14	Synthego Corporation	Biopolymer synthesis system and method
WO2019060907A1 (fr)	2017-09-25	2019-03-28	Fred Hutchinson Cancer Research Center	Profilage pangénomique in situ ciblé de haute efficacité
WO2019084043A1 (fr)	2017-10-26	2019-05-02	10X Genomics, Inc.	Méthodes et systèmes de préparation d'acide nucléique et d'analyse de chromatine
US10907205B2 (en)	2017-11-02	2021-02-02	Bio-Rad Laboratories, Inc.	Transposase-based genomic analysis
CN111051523B (zh)	2017-11-15	2024-03-19	10X基因组学有限公司	功能化凝胶珠
US10829815B2 (en)	2017-11-17	2020-11-10	10X Genomics, Inc.	Methods and systems for associating physical and genetic properties of biological particles
EP3749740B1 (fr)	2018-02-05	2023-08-30	The Board Of Trustees Of The Leland Stanford Junior University	Systèmes et procédés pour des mesures multiplexées dans des cellules uniques et d'ensemble
SG11202007686VA (en)	2018-02-12	2020-09-29	10X Genomics Inc	Methods characterizing multiple analytes from individual cells or cell populations
WO2019195166A1 (fr)	2018-04-06	2019-10-10	10X Genomics, Inc.	Systèmes et procédés de contrôle de qualité dans un traitement de cellules uniques
GB201807793D0 (en)	2018-05-14	2018-06-27	Oxford Nanopore Tech Ltd	Method
US11932899B2 (en)	2018-06-07	2024-03-19	10X Genomics, Inc.	Methods and systems for characterizing nucleic acid molecules
SG11202101164TA (en)	2018-08-03	2021-03-30	10X Genomics Inc	Methods and systems to minimize barcode exchange
US12065688B2 (en)	2018-08-20	2024-08-20	10X Genomics, Inc.	Compositions and methods for cellular processing
CN113166807B (zh)	2018-08-20	2024-06-04	生物辐射实验室股份有限公司	通过分区中条码珠共定位生成核苷酸序列
US11845983B1 (en)	2019-01-09	2023-12-19	10X Genomics, Inc.	Methods and systems for multiplexing of droplet based assays
US11467153B2 (en)	2019-02-12	2022-10-11	10X Genomics, Inc.	Methods for processing nucleic acid molecules
EP3924505B1 (fr)	2019-02-12	2025-12-17	10X Genomics, Inc.	Procédés de traitement de molécules d'acides nucléiques
WO2020167866A1 (fr)	2019-02-12	2020-08-20	10X Genomics, Inc.	Systèmes et procédés pour le chargement de transposons
CN112888791A (zh)	2019-04-29	2021-06-01	伊鲁米那股份有限公司	通过快速温育和核酸富集来鉴定和分析微生物样本
AU2020342793A1 (en)	2019-09-06	2022-04-21	Cemm - Forschungszentrum Für Molekulare Medizin Gmbh	Method for sequencing RNA oligonucleotides
US12469162B2 (en)	2020-08-31	2025-11-11	Element Biosciences, Inc.	Primary analysis in next generation sequencing
US12371743B2 (en)	2022-03-04	2025-07-29	Element Biosciences, Inc.	Double-stranded splint adaptors and methods of use
US12505571B2 (en)	2020-08-31	2025-12-23	Element Biosciences, Inc.	Primary analysis in next generation sequencing
US12359193B2 (en)	2022-03-04	2025-07-15	Element Biosciences, Inc.	Single-stranded splint strands and methods of use
CN115927244B (zh) *	2022-05-26	2026-01-02	上海墨卓生物科技有限公司	一种基于微流控技术的单细胞ChIP-seq文库的构建方法
IL317477A (en)	2022-07-05	2025-02-01	Element Biosciences Inc	PCR-free library preparation using double-stranded probe adapters and methods of use
CN119654454A (zh)	2022-07-25	2025-03-18	东洋纺株式会社	用于下一代测序分析等的片段化及标签片段化方法
IL319170A (en)	2022-09-12	2025-04-01	Element Biosciences Inc	Double-stranded probe adapters with universal long probe strands and methods of use
CN115537408B (zh) *	2022-10-08	2025-04-18	厦门大学	一种单细胞多组学文库及其构建方法
WO2025191535A1 (fr)	2024-03-15	2025-09-18	Element Biosciences, Inc.	Adaptateurs attelle partiellement double brin et procédés d'utilisation
WO2026096494A1 (fr)	2024-10-29	2026-05-07	Element Biosciences, Inc.	Procédés simplifiés de préparation de banques d'acides nucléiques et de séquençage

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4469863A (en)	1980-11-12	1984-09-04	Ts O Paul O P	Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US5034506A (en)	1985-03-15	1991-07-23	Anti-Gene Development Group	Uncharged morpholino-based polymers having achiral intersubunit linkages
US5235033A (en)	1985-03-15	1993-08-10	Anti-Gene Development Group	Alpha-morpholino ribonucleoside derivatives and polymers thereof
US5216141A (en)	1988-06-06	1993-06-01	Benner Steven A	Oligonucleotide analogs containing sulfur linkages
US5386023A (en)	1990-07-27	1995-01-31	Isis Pharmaceuticals	Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
US5602240A (en)	1990-07-27	1997-02-11	Ciba Geigy Ag.	Backbone modified oligonucleotide analogs
US5432272A (en)	1990-10-09	1995-07-11	Benner; Steven A.	Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
US5644048A (en)	1992-01-10	1997-07-01	Isis Pharmaceuticals, Inc.	Process for preparing phosphorothioate oligonucleotides
US5637684A (en)	1994-02-23	1997-06-10	Isis Pharmaceuticals, Inc.	Phosphoramidate and phosphorothioamidate oligomeric compounds
US5677170A (en)	1994-03-02	1997-10-14	The Johns Hopkins University	In vitro transposition of artificial transposons
US6271205B1 (en) *	1994-09-21	2001-08-07	University Of Massachusetts Medical Center	Cancer treatment by expression of differentiation factor receptor
US5925545A (en) *	1996-09-09	1999-07-20	Wisconsin Alumni Research Foundation	System for in vitro transposition
US5965443A (en)	1996-09-09	1999-10-12	Wisconsin Alumni Research Foundation	System for in vitro transposition
FI103809B1 (fi)	1997-07-14	1999-09-30	Finnzymes Oy	In vitro -menetelmä templaattien tuottamiseksi DNA-sekventointia varten
US6544732B1 (en)	1999-05-20	2003-04-08	Illumina, Inc.	Encoding and decoding of array sensors utilizing nanocrystals
GB0326073D0 (en) *	2003-11-07	2003-12-10	Solexa Ltd	Improvements in or relating to polynucleotide arrays
EP2038429B1 (fr)	2006-06-30	2013-08-21	Nugen Technologies, Inc.	Procédés de fragmentation et de marquage d'acides nucléiques
US7754429B2 (en)	2006-10-06	2010-07-13	Illumina Cambridge Limited	Method for pair-wise sequencing a plurity of target polynucleotides
US9080211B2 (en)	2008-10-24	2015-07-14	Epicentre Technologies Corporation	Transposon end compositions and methods for modifying nucleic acids
WO2012103545A1 (fr) *	2011-01-28	2012-08-02	Illumina, Inc.	Remplacement d'oligonucléotides pour bibliothèques marquées aux deux extrémités et directionnelles
US9683230B2 (en) *	2013-01-09	2017-06-20	Illumina Cambridge Limited	Sample preparation on a solid support

2012
- 2012-01-30 WO PCT/US2012/023139 patent/WO2012103545A1/fr not_active Ceased
- 2012-01-30 EP EP12707675.0A patent/EP2668273B9/fr active Active
- 2012-01-30 CA CA2821559A patent/CA2821559C/fr active Active
- 2012-01-30 AU AU2012211081A patent/AU2012211081B2/en active Active
- 2012-01-30 DK DK12707675.0T patent/DK2668273T3/en active
- 2012-01-30 ES ES16155567T patent/ES2762866T3/es active Active
- 2012-01-30 US US13/979,346 patent/US9238671B2/en active Active
- 2012-01-30 DK DK16155567.7T patent/DK3037536T3/da active
- 2012-01-30 EP EP16155567.7A patent/EP3037536B1/fr active Active
- 2012-01-30 ES ES12707675.0T patent/ES2568910T3/es active Active
2015
- 2015-12-08 US US14/963,021 patent/US10287574B2/en active Active
2019
- 2019-04-01 US US16/372,207 patent/US11008567B2/en active Active
2021
- 2021-04-29 US US17/244,365 patent/US20210261951A1/en active Pending

Also Published As

Publication number	Publication date
AU2012211081A1 (en)	2013-07-04
DK2668273T3 (en)	2016-04-18
EP2668273B9 (fr)	2017-03-29
US20190225960A1 (en)	2019-07-25
US20160090591A1 (en)	2016-03-31
ES2568910T3 (es)	2016-05-05
US20140031261A1 (en)	2014-01-30
EP2668273B1 (fr)	2016-04-06
EP3037536A1 (fr)	2016-06-29
EP3037536B1 (fr)	2019-11-27
AU2012211081B2 (en)	2016-02-04
WO2012103545A1 (fr)	2012-08-02
US9238671B2 (en)	2016-01-19
US10287574B2 (en)	2019-05-14
US20210261951A1 (en)	2021-08-26
US11008567B2 (en)	2021-05-18
CA2821559A1 (fr)	2012-08-02
CA2821559C (fr)	2017-01-31
DK3037536T3 (da)	2020-01-13
EP2668273A1 (fr)	2013-12-04

Publication	Publication Date	Title
US11008567B2 (en)	2021-05-18	Oligonucleotide replacement for di-tagged and directional libraries
US20240384262A1 (en)	2024-11-21	Linking sequence reads using paired code tags
CA2821299C (fr)	2019-02-12	Liaison entre des lectures de sequences a l'aide de codes marqueurs apparies
US8829171B2 (en)	2014-09-09	Linking sequence reads using paired code tags
ES2724824T3 (es)	2019-09-16	Métodos para la secuenciación de ácidos nucleicos
AU2021344868A9 (en)	2023-07-06	Self-targeting expression vector
CN113939590A (zh)	2022-01-14	用于在包含发夹环的多核苷酸模板的末端上产生非对称接头并从其测序的方法
CA2972275A1 (fr)	2016-07-07	Procedes de marquage de banques codees par de l'adn
US20060141452A1 (en)	2006-06-29	Method For Synthesizing Single-Stranded Nucleic Acid
ES2835899T3 (es)	2021-06-23	Cebador para PCR unido a secuencia complementaria de nucleótidos o secuencia complementaria de nucleótidos que incluye nucleótidos mal apareados y método para amplificar ácido nucleico mediante el uso del mismo
EP3980556A1 (fr)	2022-04-13	Capture de cible liée
NZ733158A (en)		Methods for tagging dna-encoded libraries